2kdg: Difference between revisions

No edit summary
No edit summary
 
Line 1: Line 1:


==Solution Structure of the 1st Ig domain of Myotilin==
==Solution Structure of the 1st Ig domain of Myotilin==
<StructureSection load='2kdg' size='340' side='right'caption='[[2kdg]], [[NMR_Ensembles_of_Models | 25 NMR models]]' scene=''>
<StructureSection load='2kdg' size='340' side='right'caption='[[2kdg]]' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[2kdg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KDG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2KDG FirstGlance]. <br>
<table><tr><td colspan='2'>[[2kdg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KDG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2KDG FirstGlance]. <br>
</td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MYOT, TTID ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kdg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kdg OCA], [https://pdbe.org/2kdg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kdg RCSB], [https://www.ebi.ac.uk/pdbsum/2kdg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kdg ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kdg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kdg OCA], [https://pdbe.org/2kdg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kdg RCSB], [https://www.ebi.ac.uk/pdbsum/2kdg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kdg ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[https://www.uniprot.org/uniprot/MYOTI_HUMAN MYOTI_HUMAN]] Defects in MYOT are the cause of limb-girdle muscular dystrophy type 1A (LGMD1A) [MIM:[https://omim.org/entry/159000 159000]]. LGMD1A is an autosomal dominant degenerative myopathy with onset within a mean age of 28 years. LGMD1A is characterized by progressive skeletal muscle weakness of the hip and shoulder girdles, later progressing to include distal weakness, as well as a distinctive dysarthric pattern of speech. Affected muscle exhibits disorganization and streaming of the Z-line.<ref>PMID:10958653</ref> <ref>PMID:12428213</ref>  Defects in MYOT are the cause of myopathy myofibrillar type 3 (MFM3) [MIM:[https://omim.org/entry/609200 609200]]. A neuromuscular disorder characterized by progressive skeletal muscle weakness greater distally than proximally, tight heel cords, hyporeflexia, cardiomyopathy and peripheral neuropathy in some patients. Affected muscle exhibits disorganization and streaming of the Z-line, presence of large hyaline structures, excessive accumulation of myotilin and other ectopically expressed proteins and prominent congophilic deposits.<ref>PMID:15111675</ref>  Defects in MYOT are the cause of spheroid body myopathy (SBM) [MIM:[https://omim.org/entry/182920 182920]]. SBM is an autosomal dominant form of myofibrillar myopathy (MFM), characterized by slowly progressing proximal muscle weakness and dysarthric nasal speech. There is no evidence of cardiomyopathy. Muscle biopsy shows spheroid bodies within the type I muscle fibers.<ref>PMID:16380616</ref>
[https://www.uniprot.org/uniprot/MYOTI_HUMAN MYOTI_HUMAN] Defects in MYOT are the cause of limb-girdle muscular dystrophy type 1A (LGMD1A) [MIM:[https://omim.org/entry/159000 159000]. LGMD1A is an autosomal dominant degenerative myopathy with onset within a mean age of 28 years. LGMD1A is characterized by progressive skeletal muscle weakness of the hip and shoulder girdles, later progressing to include distal weakness, as well as a distinctive dysarthric pattern of speech. Affected muscle exhibits disorganization and streaming of the Z-line.<ref>PMID:10958653</ref> <ref>PMID:12428213</ref>  Defects in MYOT are the cause of myopathy myofibrillar type 3 (MFM3) [MIM:[https://omim.org/entry/609200 609200]. A neuromuscular disorder characterized by progressive skeletal muscle weakness greater distally than proximally, tight heel cords, hyporeflexia, cardiomyopathy and peripheral neuropathy in some patients. Affected muscle exhibits disorganization and streaming of the Z-line, presence of large hyaline structures, excessive accumulation of myotilin and other ectopically expressed proteins and prominent congophilic deposits.<ref>PMID:15111675</ref>  Defects in MYOT are the cause of spheroid body myopathy (SBM) [MIM:[https://omim.org/entry/182920 182920]. SBM is an autosomal dominant form of myofibrillar myopathy (MFM), characterized by slowly progressing proximal muscle weakness and dysarthric nasal speech. There is no evidence of cardiomyopathy. Muscle biopsy shows spheroid bodies within the type I muscle fibers.<ref>PMID:16380616</ref>  
== Function ==
== Function ==
[[https://www.uniprot.org/uniprot/MYOTI_HUMAN MYOTI_HUMAN]] Component of a complex of multiple actin cross-linking proteins. Involved in the control of myofibril assembly and stability at the Z lines in muscle cells.<ref>PMID:12499399</ref>
[https://www.uniprot.org/uniprot/MYOTI_HUMAN MYOTI_HUMAN] Component of a complex of multiple actin cross-linking proteins. Involved in the control of myofibril assembly and stability at the Z lines in muscle cells.<ref>PMID:12499399</ref>  
== Evolutionary Conservation ==
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
[[Image:Consurf_key_small.gif|200px|right]]
Line 37: Line 37:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Carpen, O]]
[[Category: Carpen O]]
[[Category: Heikkinen, O]]
[[Category: Heikkinen O]]
[[Category: Kilpelainen, I]]
[[Category: Kilpelainen I]]
[[Category: Koskela, H]]
[[Category: Koskela H]]
[[Category: Permi, P]]
[[Category: Permi P]]
[[Category: Ylanne, J]]
[[Category: Ylanne J]]
[[Category: Actin-binding]]
[[Category: Cell membrane]]
[[Category: Cytoplasm]]
[[Category: Cytoskeleton]]
[[Category: Disease mutation]]
[[Category: Immonoglobulin domain]]
[[Category: Immunoglobulin domain]]
[[Category: Limb-girdle muscular dystrophy]]
[[Category: Membrane]]
[[Category: Muscle protein]]
[[Category: Myotilin]]
[[Category: Polymorphism]]
[[Category: Structural protein]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA